Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Jun 1, 2026, 9:30 AM EST

Nutra Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1.1-2.05-1.29-1.398.18-13.1
Depreciation & Amortization
0.080.10.090.10.120.06
Other Amortization
0.290.290.130.140.540.33
Loss (Gain) From Sale of Assets
----0.04--
Stock-Based Compensation
0.040.03--0.020.15
Provision & Write-off of Bad Debts
0.050.05-0.110.070.07
Other Operating Activities
-0.830.20.240.2-10.8510.66
Change in Accounts Receivable
-0.01-0.02-0.01-00.02-0.01
Change in Inventory
0.010.010.01-0.040.03-0.05
Change in Accounts Payable
0.040.050.060.040.050.07
Change in Unearned Revenue
--0.010.050.18-
Change in Other Net Operating Assets
0.350.170.320.30.880.06
Operating Cash Flow
-1.09-1.16-0.42-0.55-0.76-1.74
Capital Expenditures
--0.03---0.06-0.04
Sale of Property, Plant & Equipment
---0.08--
Investment in Securities
---0.03--
Other Investing Activities
-0.03-0.030.0400.09-0.25
Investing Cash Flow
-0.03-0.050.040.120.03-0.29
Short-Term Debt Issued
-0.550.530.60.10.11
Long-Term Debt Issued
-1.160.440.311.222.29
Total Debt Issued
1.591.720.970.911.332.39
Short-Term Debt Repaid
--0.2-0.21-0.16-0.27-0.18
Long-Term Debt Repaid
--0.33-0.35-0.31-0.42-0.08
Total Debt Repaid
-0.47-0.53-0.55-0.48-0.68-0.27
Net Debt Issued (Repaid)
1.121.190.420.430.642.13
Financing Cash Flow
1.121.190.420.430.642.13
Net Cash Flow
0.01-0.020.04--0.090.09
Free Cash Flow
-1.09-1.19-0.42-0.55-0.82-1.78
Free Cash Flow Margin
-336.32%-308.85%-108.11%-92.46%-187.19%-1824.84%
Cash Interest Paid
0.050.050.040.090.080.04
Levered Free Cash Flow
-1.1-0.3-0.220.01-9.645.27
Unlevered Free Cash Flow
-1.12-0.31-0.160.12-9.695.25
Change in Working Capital
0.380.210.390.341.160.08